Prediction and prevention of thromboembolic events with enoxaparin in cancer patients with elevated tissue factor-bearing microparticles: a randomized-controlled phase II trial (the Microtec study) - Zwicker, J I; Liebman, H A; Bauer, K A (Br J Haematol, 2013)
, et al.